Parkside Financial Bank & Trust’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.82K | Hold |
22
| – | – | ﹤0.01% | 2213 |
|
|
2026
Q1 | $1.69K | Hold |
22
| – | – | ﹤0.01% | 2177 |
|
|
2025
Q4 | $1.74K | Hold |
22
| – | – | ﹤0.01% | 2154 |
|
|
2025
Q3 | $2.02K | Hold |
22
| – | – | ﹤0.01% | 2026 |
|
|
2025
Q2 | $1.44K | Buy |
22
+9
| +69% | +$586 | ﹤0.01% | 2113 |
|
|
2025
Q1 | $871 | Buy |
13
+10
| +333% | +$597 | ﹤0.01% | 2162 |
|
|
2024
Q4 | $166 | Hold |
3
| – | – | ﹤0.01% | 2079 |
|
|
2024
Q3 | $179 | Hold |
3
| – | – | ﹤0.01% | 2025 |
|
|
2024
Q2 | $192 | Hold |
3
| – | – | ﹤0.01% | 1949 |
|
|
2024
Q1 | $208 | Hold |
3
| – | – | ﹤0.01% | 1927 |
|
|
2023
Q4 | $166 | Sell |
3
-31
| -91% | -$1.71K | ﹤0.01% | 1976 |
|
|
2023
Q3 | $1.98K | Hold |
34
| – | – | ﹤0.01% | 1667 |
|
|
2023
Q2 | $1.83K | Hold |
34
| – | – | ﹤0.01% | 1715 |
|
|
2023
Q1 | $1.35K | Hold |
34
| – | – | ﹤0.01% | 1789 |
|
|
2022
Q4 | $1.37K | Hold |
34
| – | – | ﹤0.01% | 1779 |
|
|
2022
Q3 | $1K | Buy |
+34
| New | +$1.16K | ﹤0.01% | 1629 |
|
|
2022
Q1 | – | Sell |
-53
| Closed | -$2K | – | 1822 |
|
|
2021
Q4 | $2K | Buy |
+53
| New | +$2.28K | ﹤0.01% | 1568 |
|
|
2021
Q3 | – | Sell |
-155
| Closed | -$5K | – | 1748 |
|
|
2021
Q2 | $5K | Buy |
+155
| New | +$5.27K | ﹤0.01% | 1211 |
|
|
2020
Q4 | – | Sell |
-28
| Closed | -$1K | – | 1597 |
|
|
2020
Q3 | $1K | Buy |
28
+15
| +115% | +$447 | ﹤0.01% | 1275 |
|
|
2020
Q2 | $0 | Buy |
+13
| New | +$466 | ﹤0.01% | 1476 |
|
|
2020
Q1 | – | Sell |
-8
| Closed | – | – | 1420 |
|
|
2019
Q4 | $0 | Sell |
8
-3
| -27% | -$199 | ﹤0.01% | 1580 |
|
|
2019
Q3 | $1K | Hold |
11
| – | – | ﹤0.01% | 1284 |
|
|
2019
Q2 | $1K | Buy |
11
+5
| +83% | +$356 | ﹤0.01% | 1299 |
|
|
2019
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 1537 |
|
|
2018
Q4 | $0 | Sell |
6
-10
| -63% | -$524 | ﹤0.01% | 1445 |
|
|
2018
Q3 | $1K | Hold |
16
| – | – | ﹤0.01% | 1201 |
|
|
2018
Q2 | $1K | Hold |
16
| – | – | ﹤0.01% | 1173 |
|
|
2018
Q1 | $1K | Buy |
16
+10
| +167% | +$635 | ﹤0.01% | 1112 |
|
|
2017
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 1359 |
|
|
2017
Q3 | $0 | Buy |
+6
| New | +$286 | ﹤0.01% | 1365 |
|
|
2017
Q1 | – | Sell |
-4
| Closed | – | – | 1351 |
|
|
2016
Q4 | $0 | Buy |
+4
| New | +$245 | ﹤0.01% | 1360 |
|
Other funds holding ANIP
SCM
TCM
GACM
Parkside Financial Bank & Trust's ANIP Position: Q2 2026 in Review
Parkside Financial Bank & Trust held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 22 shares worth $1.82K. The position accounts for ﹤0.01% of the portfolio, ranked #2213.
Parkside Financial Bank & Trust first reported a position in ANIP in Q4 2016 and has held it in 31 quarters since. The position peaked at $5K in Q2 2021. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.
- Parkside Financial Bank & Trust held 22 shares of ANI Pharmaceuticals worth $1.82K as of Q2 2026.
- Parkside Financial Bank & Trust left its ANI Pharmaceuticals share count unchanged in Q2 2026.
- ANI Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2213 holding.
- Parkside Financial Bank & Trust first reported a position in ANI Pharmaceuticals in Q4 2016 and has held it in 31 quarters since.
- Parkside Financial Bank & Trust's ANI Pharmaceuticals position peaked at $5K in Q2 2021.
- 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.